Case Study on Immunogenicity Testing from Non-clinical to Clinical
Authored by: Deborah Finco, Ph.D., Senior Principal Scientist, Drug Safety R&D, Pfizer, Inc.
* - required fields
View All Sponsors
View Media Partners
View 2013 Attendee List
Reducing and Monitoring Bioassay Variability
2013 Speaker: Janet L. Lathey, Ph.D., Director, Immunology and Assay Development, BioDefenseDivision, Emergent BioSolutions